← Leaderboards
David Harlan
Diabetes, Digestive, Kidney Diseases
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Diabetes, Digestive, Kidney Diseases
Same institution · by research overlap
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinBeta CellDiabetes MellitusStructure Of Beta Cell Of IsletCellsReportingT-LymphocytePancreasMediatingDiabetes Mellitus, Insulin-DependentIsletAutoimmune ProcessBlood GlucoseManuscriptsPancreatic Islet FunctionInsulin Dependent Diabetes MellitusResearch PersonnelNumbersBaseRodentMouse ModelPublishingStem CellsEnrollment
Grant awards (61)
Immunological Mechanisms Underlying T1dm Pathogenesis$214,528
ZIA · FY2010 · DK · contact PI
Inpatient and outpatient infrastructure for T1DM clinical protocols$202,610
ZIA · FY2010 · DK · contact PI
Rodent pancreatic islet biology in health and disease$190,692
ZIA · FY2010 · DK · contact PI
Mouse model to assess putative beta cell progenitor cells$190,692
ZIA · FY2010 · DK · contact PI
Transplant-based treatment approaches for T1DM$131,100
ZIA · FY2010 · DK · contact PI
Preclinical studies for measuring beta cell mass in vivo$131,100
ZIA · FY2010 · DK · contact PI
Novel techniques for assessing beta cell turnover$131,100
ZIA · FY2010 · DK · contact PI
Secondary Prevention Trials For Recently Diagnosed Type 1 Diabetes Mellitus$429,752
ZIA · FY2009 · DK · contact PI
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)$429,752
ZIA · FY2009 · DK · contact PI
Inpatient and outpatient infrastructure for T1DM clinical protocols$340,961
ZIA · FY2009 · DK · contact PI
Rodent pancreatic islet biology in health and disease$320,904
ZIA · FY2009 · DK · contact PI
Mouse model to assess putative beta cell progenitor cells$320,904
ZIA · FY2009 · DK · contact PI
Immunological Mechanisms Underlying T1dm Pathogenesis$240,678
ZIA · FY2009 · DK · contact PI
Preclinical studies for measuring beta cell mass in vivo$220,622
ZIA · FY2009 · DK · contact PI
Novel techniques for assessing beta cell turnover$220,622
ZIA · FY2009 · DK · contact PI
Transplant-based treatment approaches for T1DM$220,622
ZIA · FY2009 · DK · contact PI
Assessing a PET-based technique for characterizing beta cell mass in vivo$120,339
ZIA · FY2009 · DK · contact PI
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)$284,071
Z01 · FY2008 · DK · contact PI
Inpatient and outpatient infrastructure for T1DM clinical protocols$279,534
Z01 · FY2008 · DK · contact PI
Rodent pancreatic islet biology in health and disease$279,534
Z01 · FY2008 · DK · contact PI
Transplant-based treatment approaches for T1DM$263,906
Z01 · FY2008 · DK · contact PI
Immunological Mechanisms Underlying T1dm Pathogenesis$263,906
Z01 · FY2008 · DK · contact PI
Assessing a PET-based technique for characterizing beta cell mass in vivo$248,530
Z01 · FY2008 · DK · contact PI
Preclinical studies for measuring beta cell mass in vivo$248,530
Z01 · FY2008 · DK · contact PI
Mouse model to assess putative beta cell progenitor cells$217,527
Z01 · FY2008 · DK · contact PI
Secondary Prevention Trials For Recently Diagnosed Type 1 Diabetes Mellitus$217,527
Z01 · FY2008 · DK · contact PI
Novel techniques for assessing beta cell turnover$217,527
Z01 · FY2008 · DK · contact PI
03-DK-0245 (Effect of AC2993 (synthetic exendin-4) on pancreatic islet function)$324,715
Z01 · FY2007 · DK · contact PI
Inpatient and outpatient infrastructure for T1DM clinical protocols$319,614
Z01 · FY2007 · DK · contact PI
Rodent pancreatic islet biology in health and disease$319,614
Z01 · FY2007 · DK · contact PI
Transplant-based treatment approaches for T1DM$301,918
Z01 · FY2007 · DK · contact PI
Immunological Mechanisms Underlying T1dm Pathogenesis$301,918
Z01 · FY2007 · DK · contact PI
Preclinical studies for measuring beta cell mass in vivo$284,165
Z01 · FY2007 · DK · contact PI
Assessing a PET-based technique for characterizing beta cell mass in vivo$284,165
Z01 · FY2007 · DK · contact PI
Secondary Prevention Trials For Recently Diagnosed Type 1 Diabetes Mellitus$248,630
Z01 · FY2007 · DK · contact PI
Mouse model to assess putative beta cell progenitor cells$248,630
Z01 · FY2007 · DK · contact PI
Novel techniques for assessing beta cell turnover$248,630
Z01 · FY2007 · DK · contact PI
Islet Cell Transplantation For T1dm: Clinical Studies An$0
Z01 · FY2006 · DK · contact PI
Immunological Mechanisms Underlying T1dm Pathogenesis$0
Z01 · FY2006 · DK · contact PI
Immunological Mechanisms Underlying T1dm Pathogenesis$0
Z01 · FY2005 · DK
Islet Cell Transplantation For T1dm--Clinical Studies$0
Z01 · FY2005 · DK
Islet Cell Transplantation For T1DM: Clinical Studies$0
Z01 · FY2004 · DK
Islet Cell Transplantation For T1dm: Clinical Studies$0
Z01 · FY2003 · DK
Immunological Mechanisms Underlying T1dm Pathogenesis$0
Z01 · FY2003 · DK
Immunological Mechanisms Underlying Allograft Rejection$0
Z01 · FY2003 · DK
T-lymphocyte Signaling In Autoimmune Illness And Allogra$0
Z01 · FY2002 · DK
Immunological Mechanisms Underlying T1dm Pathogenesis$0
Z01 · FY2002 · DK
Immunological Mechanisms Underlying Allograft Rejection,$0
Z01 · FY2002 · DK
Islet Cell Transplantation For T1dm: Clinical Studies An$0
Z01 · FY2002 · DK
T-lymphocyte Signaling In Autoimmune Illness And Allogra$0
Z01 · FY2001 · DK
Immunological Mechanisms Underlying Allograft Rejection,$0
Z01 · FY2001 · DK
Islet Cell Transplantation For T1dm: Clinical Studies An$0
Z01 · FY2001 · DK
Kidney/pancreas Allograft Rejection: Clinical Studies An$0
Z01 · FY2001 · DK
Immunological Mechanisms Underlying T1dm Pathogenesis$0
Z01 · FY2001 · DK
Secondary Prevention Trials For Recently Diagnosed T1DM$0
Z01 · FY2001 · DK
T-lymphocyte signaling in autoimumune illness and allogr$0
Z01 · FY2000 · DK
Secondary prevention trials for recently diagnosed T1DM$0
Z01 · FY2000 · DK
Immunological mechanisms underlying T1DM pathogenesis$0
Z01 · FY2000 · DK
Kidney/pancreas allograft rejection: clinical studies$0
Z01 · FY2000 · DK
Islet cell transplantation for T1DM: clinical studies$0
Z01 · FY2000 · DK
Immunologic mechanisms underlying allograft rejection$0
Z01 · FY2000 · DK